Advanced search×

Introducing radiotherapy to Oman.

Bidhu Kalyan BK Mohanti

Eur J Cancer 44(3):333 (2008) PMID 18437722

Version: za2963e q8za0 q8zb4 q8zc4 q8zd4 q8zeb q8zff q8zgd

Similar articles you may find interesting…

  1. Accessibility to targeted oncology drugs in Slovenia and selected European countries
    Mitja M Kos, Marko M Obradovic, and Ales A Mrhar

    Eur J Cancer 44(3):11 (2008) PMID 18155900

    The time of introduction of targeted oncology drugs in Slovenia was in most cases similar to the comparison countries, except for alemtuzumab and rituximab. The utilisation of targeted oncology drugs in Slovenia was in most cases lower than in other comparison countries. Ibritumomab had not been use...
  2. Primary amelanotic melanoma of the breast: combating a rare cancer.
    Ahitagni Biswas, Shikha Goyal, ... Goura Kishor Rath

    Breast Cancer (2010) PMID 20978954

    We herein describe a case of primary amelanotic melanoma of the breast parenchyma in a 32-year-old female managed with a combination of surgery, adjuvant radiotherapy and immunotherapy. CONCLUSION: This case report aims to increase awareness of unusual neoplasms of the breast which might require a d...
  3. Spinal intradural primary germ cell tumour--review of literature and case report.
    Ahitagni A Biswas, Tarun T Puri, ... Goura Kishor GK Rath

    Acta Neurochir (Wien) 151(3):277-84 (2009) PMID 19240975

    The median age at presentation was 24 years. The most common location of the tumour was thoracic (40%). Beta-HCG overproduction was noted in 40% of the patients. Most patients were treated with a combination of surgery, radiation therapy, and systemic chemotherapy. Median follow-up was 16.5 months....